CAMT Stock Analysis: Camtek | NASDAQ

Inspection Equipment, Metrology Tools, Advanced Packaging, Wafer Metrology

Total Rating 54

Safety 71

Buy Signal -0.77

Semiconductor Equipment & Materials
Industry Rotation: +13.5

Market Cap: 6.69B
Avg Turnover: 66.3M

Risk 3d forecast

Volatility72.9%

VaR 5^th Pctl12.9%

VaR vs Median7.33%

Reward TTM

Sharpe Ratio0.91

Rel. Str. IBD49.3

Rel. Str. Peer Group20.3

Character TTM

Beta2.149

Beta Downside1.972

Hurst Exponent0.500

Drawdowns 3y

Max DD63.16%

CAGR/Max DD0.51

CAGR/Mean DD1.42

EPS (Earnings per Share)

EPS CAGR: 20.72%
EPS Trend: 91.8%

Last SUE: 0.98
Qual. Beats: 1

Revenue

Rev. CAGR: 21.94%
Rev. Trend: 97.0%

Last SUE: 2.62
Qual. Beats: 2

Warnings

P/E Ratio 196.2

Volatile

Below Avwap Earnings

Below Sma 200d

Tailwinds

Confidence

Seasonality 11.6 years of data

Jan +2.5% 29

Feb +1.6% 5

Mar -2.8% 32

Apr +2.5% 5

May +5.4% 22

Jun -4.3% 16

Jul +10.4% 32

Aug -6.7% 27

Sep -2.5% 26

Oct +0.2% 0

Nov +1.8% 14

Dec -2.2% 27

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: CAMT Camtek

Camtek Ltd. (NASDAQ: CAMT) is an Israel-based manufacturer of inspection and metrology equipment used in semiconductor fabrication and packaging. The company sells its systems globally, with a customer base spanning the United States, China, Korea, Europe, and the broader Asia Pacific region. It serves semiconductor manufacturers, outsourced semiconductor assembly and test (OSAT) providers, integrated device manufacturers (IDMs), and wafer-level packaging subcontractors. The inspection and metrology segment is a critical part of the semiconductor supply chain, as these tools are used to detect defects and verify dimensions at various stages of chip production, directly impacting yield and quality control.

Camteks product portfolio is organized around two main platforms. The Eagle family (including Eagle G5, Eagle-i/Plus, and Eagle-AP/Plus) and the Hawk platform target the advanced packaging market, an area that has gained prominence with the rise of 2.5D/3D packaging, chiplets, and high-bandwidth memory used in AI and high-performance computing applications. The Golden Eagle platform addresses standard panel-level inspection, while the MicroProf line (AP, DI, FE, FS, PT, MHU, TL, 200, and 300) covers wafer-level metrology, surface measurement, and material handling for the semiconductor, MEMS, sapphire, and LED industries.

The company was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel. Listed on NASDAQ since 2000, Camtek is classified within the Information Technology sector under the Semiconductor Materials & Equipment sub-industry, reflecting its role as a specialized equipment vendor to chip producers rather than a chip designer or fab operator itself.

Headlines to Watch Out For

HBM and AI chip demand lifts advanced packaging metrology orders
China revenue concentration exposes stock to export control risk
Semiconductor capex recovery drives inspection equipment backlog growth

Piotroski VR-10 (Strict) 4.0

Net Income: 37.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA -11.63 > 1.0
NWC/Revenue: 157.0% < 20% (prev 121.5%; Δ 35.49% < -1%)
CFO/TA 0.11 > 3% & CFO 141.9m > Net Income 37.7m
Net Debt (-99.6m) to EBITDA (129.8m): -0.77 < 3
Current Ratio: 7.38 > 1.5 & < 3
Outstanding Shares: last quarter (51.5m) vs 12m ago 4.45% < -2%
Gross Margin: 50.05% > 18% (prev 50.29%; Δ -0.24% > 0.5%)
Asset Turnover: 44.00% > 50% (prev 48.38%; Δ -4.38% > 0%)
Interest Coverage Ratio: 71.27 > 6 (EBIT TTM 118.0m / Interest Expense TTM 1.66m)

Altman Z'' 6.86

A: 0.60 (Total Current Assets 924.4m - Total Current Liabilities 125.3m) / Total Assets 1.34b
B: 0.33 (Retained Earnings 441.5m / Total Assets 1.34b)
C: 0.10 (EBIT TTM 118.0m / Avg Total Assets 1.16b)
D: 1.13 (Book Value of Equity 710.2m / Total Liabilities 628.9m)
Altman-Z'' = 6.86 = AAA

Beneish M -2.78

DSRI: 1.12 (Receivables 153.9m/127.8m, Revenue 509.0m/471.6m)
GMI: 1.00 (GM 50.29% / 50.05%)
AQI: 1.17 (AQ_t 0.26 / AQ_t-1 0.22)
SGI: 1.08 (Revenue 509.0m / 471.6m)
TATA: -0.08 (NI 37.7m - CFO 141.9m) / TA 1.34b)
Beneish M = -2.78 (Cap -4..+1) = A

What is the price of CAMT shares?

As of August 31, 2026, the stock is trading at USD 135.57 with a total of 231,960 shares traded. Over the past week, the price has changed by -7.66%, over one month by -1.21%, over three months by -16.87% and over the past year by +72.79%.

Current recommended Stop Loss: 121.60 (which is 10.3% or 1.4 ATR below the current price).

Is CAMT a buy, sell or hold?

Camtek has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CAMT.

StrongBuy: 5
Buy: 2
Hold: 5
Sell: 0
StrongSell: 0

What are the forecasts/targets for the CAMT price?

Analysts Target Price	185.5	36.8%

Camtek (CAMT) - Fundamental Data Overview as of 28 August 2026

Market Cap USD = 6.69b (6.69b USD * 1.0 USD.USD)
P/E Trailing = 196.2329
P/E Forward = 40.8163
P/S = 13.3947
P/B = 9.6482
P/EG = 2.9171
Revenue TTM = 509.0m USD
EBIT TTM = 118.0m USD
EBITDA TTM = 129.8m USD
Long Term Debt = 519.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 530.8m USD (corrected: LT Debt 519.8m + ST Debt none) + Leases 11.0m
Net Debt = -99.6m USD (calculated: Debt 530.8m - CCE 630.4m)
Enterprise Value = 6.59b USD (6.69b + Debt 530.8m - CCE 630.4m)
Interest Coverage Ratio = 71.27 (Ebit TTM 118.0m / Interest Expense TTM 1.66m)
EV/FCF = 133.1x (Enterprise Value 6.59b / FCF TTM 49.5m)
FCF Yield = 0.75% (FCF TTM 49.5m / Enterprise Value 6.59b)
FCF Margin = 9.72% (FCF TTM 49.5m / Revenue TTM 509.0m)
Net Margin = 7.40% (Net Income TTM 37.7m / Revenue TTM 509.0m)
Gross Margin = 50.05% ((Revenue TTM 509.0m - Cost of Revenue TTM 254.2m) / Revenue TTM)
Gross Margin QoQ = 50.06% (prev 50.08%)
Tobins Q-Ratio = 4.92 (Enterprise Value 6.59b / Total Assets 1.34b)
Interest Expense / Debt = 0.31% (Interest Expense 1.66m / Debt 530.8m)
Taxrate = 19.70% (9.24m / 46.9m)
NOPAT = 94.8m (EBIT 118.0m * (1 - 19.70%))
Current Ratio = 5.32 (Total Current Assets 924.4m / Total Current Liabilities 173.7m)
Debt / Equity = 0.75 (Debt 530.8m / totalStockholderEquity, last quarter 710.2m)
Debt / EBITDA = -0.77 (Net Debt -99.6m / EBITDA 129.8m)
Debt / FCF = -2.01 (Net Debt -99.6m / FCF TTM 49.5m)
Total Stockholder Equity = 646.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.26% (Net Income 37.7m / Total Assets 1.34b)
RoE = 5.82% (Net Income TTM 37.7m / Total Stockholder Equity 646.9m)
RoCE = 10.12% (EBIT 118.0m / Capital Employed (Equity 646.9m + L.T.Debt 519.8m))
RoIC = 7.98% (NOPAT 94.8m / Invested Capital 1.19b)
WACC = 12.56% (E(6.69b)/V(7.22b) * Re(13.54%) + D(530.8m)/V(7.22b) * Rd(0.31%) * (1-Tc(0.20)))
Discount Rate = 13.54% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 31.40 | Cagr: 2.02%
[DCF] Terminal Value 59.13% ; FCFF base≈89.5m ; Y1≈78.4m ; Y5≈63.4m
[DCF] Fair Price = 15.08 (EV 604.3m - Net Debt -99.6m = Equity 703.8m / Shares 46.7m; r=12.56% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 91.78 | EPS CAGR: 20.72% | SUE: 0.98 | # QB: 1
Revenue Correlation: 96.99 | Revenue CAGR: 21.94% | SUE: 2.62 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.98 | Chg30d=+5.33% | Revisions=-15% | Analysts=11
EPS current Year (2026-12-31): EPS=3.61 | Chg30d=+3.12% | Revisions=+18% | GrowthEPS=+10.8% | GrowthRev=+19.6%
EPS next Year (2027-12-31): EPS=4.89 | Chg30d=+7.98% | Revisions=+36% | GrowthEPS=+35.3% | GrowthRev=+27.3%
[Analyst] Revisions Ratio: +14% (up=15, down=11)